Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Human NK Cells Express CC Chemokine Receptors 4 and 8 and Respond to Thymus and Activation-Regulated Chemokine, Macrophage-Derived Chemokine, and I-309

Marit Inngjerdingen, Bassam Damaj and Azzam A. Maghazachi
J Immunol April 15, 2000, 164 (8) 4048-4054; DOI: https://doi.org/10.4049/jimmunol.164.8.4048
Marit Inngjerdingen
*Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bassam Damaj
†Tanabe Research Laboratories, San Diego, CA 92121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azzam A. Maghazachi
*Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

NK cells respond to various chemokines, suggesting that they express receptors for these chemokines. In this paper, we show that IL-2-activated NK (IANK) cells express CC chemokine receptor 4 (CCR4) and CCR8, as determined by flow cytometric, immunoblot, and RNase protection assays. Macrophage-derived chemokine (MDC), the ligand for CCR4, induces the phosphorylation of CCR4 within 0.5 min of activating IANK cells with this ligand. This is corroborated with the recruitment of G protein-coupled receptor kinases 2 and 3 and their association with CCR4 in IANK cell membranes. Also, CCR4 is internalized between 5 and 45 min but reappears in the membranes after 60 min of stimulation with MDC. MDC, thymus and activation-regulated chemokine (TARC), and I-309 induce the chemotaxis of IANK cells, an activity that is inhibited upon pretreatment of these cells with pertussis toxin, suggesting that receptors for these chemokines are coupled to pertussis toxin-sensitive G proteins. In the calcium release assay, cross-desensitization experiments showed that TARC completely desensitizes the calcium flux response induced by MDC or I-309, whereas both MDC and I-309 partially desensitize the calcium flux response induced by TARC. These results suggest that TARC utilizes CCR4 and CCR8. Our results are the first to show that IL-2-activated NK cells express CCR4 and CCR8, suggesting that these receptors are not exclusive for Th2 cells.

Chemokines are proinflammatory cytokines important for the migration of various cell types into the inflammatory sites (1, 2). They are classified into C (γ), CC (β), CXC (α), and CX3C (δ). In addition, about 10 CC, five CXC, one C, and one CX3C chemokine receptors have been cloned (reviewed in Refs. 2, 3). The CC chemokine receptor 4 (CCR4)3 was found to bind thymus and activation-regulated chemokine (TARC) (4) as well as macrophage-derived chemokine (MDC) (5). On the other hand, CCR8 was first cloned in T cells and in the NK 3.3 cell line and was given the name TER-1 (6). Later work showed that this receptor binds the CC chemokine I-309, and it was renamed CCR8 (7, 8).

The anti-viral/anti-tumor effector NK cells respond to various chemokines (9). Among the recently described chemokines, MDC is chemotactic for NK cells (10), suggesting that they express receptors for this chemokine. However, such expression has not been previously shown. In contrast, CCR4 is expressed in T cells and in particular in the Th2 subtype (11). Similarly, CCR8 is preferentially expressed in Th2 cells (12).

Chemokines play major roles in combating HIV-1 infection. The CC chemokines macrophage inflammtory protein (MIP)-1α, MIP-1β, and RANTES inhibit the replication of the M-tropic HIV-1 strains (13), whereas the CXC chemokine stromal-derived factor (SDF)-1α inhibits the replication of the T-tropic HIV-1 strains (14, 15). Recently, I-309 was reported to inhibit the replication of several HIV-1 strains (16). Also, the truncated form of MDC inhibits the replication of both HIV-1 strains (17, 18). One possible mechanism for this inhibition is the ability of chemokines to activate NK cells (reviewed in Ref. 9). The present work attempts to examine the expression of chemokine receptors (in particular CCR4 and CCR8 in NK cells) and to investigate the biological significance of these receptors.

Materials and Methods

Culture medium and other reagents

Culture medium consisted of RPMI 1640 supplemented with 10% human AB serum (Ullevål Hospital, Oslo, Norway), 10 U/ml penicillin, 100 μg/ml streptomycin, 1 mM l-glutamine, 1% nonessential amino acids (all from Life Technologies, Paisley, U.K.), and 5 × 10−5 M 2-ME (Sigma, St. Louis, MO). Ionomycin was from Biomol (SMS Norway, Olso, Norway).

Preparation of NK cells and their membranes

IL-2-activated NK (IANK) cells were prepared by adherence to plastic flasks for 10 days (in the presence of IL-2) of nylon-wool column nonadherent cells generated from buffy coats of human volunteers (Ullevål Hospital), as previously described (19). Depending on the donor, the plastic adherent cells contained between 17 and 35% CD3+ T cells. Hence, it was necessary to deplete contaminating T cells. This was accomplished by binding these cells twice to M-450 CD3-coupled beads (Dynal, Oslo, Norway). This procedure resulted in more than 95% of the cells expressing the CD56 cell surface marker and less than 5% of the cells expressing the CD3 cell surface marker. IANK cell membranes were prepared in a buffer containing 25 mM Tris, 50 mM NaCl (pH 7.5), 40 μg/ml PMSF, 10 μg/ml leupeptin, 2 μg/ml pepstatin A, and 2 μg/ml aprotinin. After homogenization and sonication, they were centrifuged at 1000 × g for 10 min, and the supernatants were transferred into Beckman tubes and ultracentrifuged at 150,000 × g for 45 min at 4°C. The membranes were transferred into a buffer containing 1% Brij, 25 mM Tris, and 150 mM NaCl.

Pretreatment with pertussis toxin (PT)

PT (Calbiochem-Novabiochem, La Jolla, CA) was activated with 20 mM DTT and 20 mM HEPES for 10 min at 37°C. IANK cells (1 × 106) were either left intact or treated with 2, 20, or 200 ng/ml of activated PT in a final concentration of 10 ml per flask and were incubated for 18 h at 37°C. The cells were collected and washed three times with complete medium. Only preparations that contained more than 95% viable cells were used in the assays described here.

Chemotaxis assay

This procedure has been described in detail (19, 20). In brief, blind-well chemotaxis chambers with a lower-well volume of 200 μl were used. A maximum volume of 200 μl of RPMI medium containing 1% BSA was placed in the lower wells in the presence or absence of various chemokines (MDC, TARC, or I-309; R&D Systems, Abingdon, Oxon, U.K.). Cells (4 × 105) were placed in the upper compartments of Boyden chambers above the filters. The chambers were incubated for 2 h at 37°C in a 5% CO2 incubator. The filters were then removed, dehydrated, and stained with 15% Giemsa stain for 7 min and then mounted on glass slides. Cells in 10 high-power fields from two filters were counted and averaged for each sample. Migration index was calculated as the number of cells migrating toward the concentration gradient of chemokines divided by the number of cells migrating toward medium only.

Measurement of intracellular Ca2+ concentration ([Ca2+]i)

IANK cells were incubated in a buffer containing 145 mM NaCl, 5 mM KCl, 10 mM Na/MOPS, 1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 0.25% BSA, 10 mM HEPES (pH 7.4), and 2.5 μM fura-2-acetoxymethyl ester (fura-2-AM) (Calbiochem, La Jolla, CA) for 45 min at 37°C. The cells were washed and resuspended at a concentration of 1 × 105 cells/ml and then incubated with the appropriate concentration of chemokines. A dual excitation luminescence spectrometer system (LS 50, Perkin-Elmer, Buckinghamshire, U.K.) containing 340- and 380-nm band pass filters was used. The emission was determined at 510 nm, and the intensity was measured by using a photomultiplier tube system. The concentration of [Ca2+]i was calculated according to the following formula: Kd (F − Fmin/Fmax − F), where Kd for fura 2 is 225 nM. F, Fmax, and Fmin were determined by measuring the experimental fluorescence, fluorescence in the presence of 10% Triton X, and fluorescence in the presence of 4 mM EGTA plus 10% Triton X, respectively. In experiments in which PT was used, the assays were done in the absence of extracellular calcium to monitor the release of calcium from intracellular stores. In these assays, the fluorescence ratio of bound/free fura 2 was measured.

Immunoblot assay

This was done as described (21). IANK cell membranes (100 μg) were suspended in 0.5 ml of 1% Brij diluted in 40 mM Tris-HCl, 150 mM NaCl (pH 7.5), and proteolytic enzyme inhibitors and were incubated with 0.5 μg of goat anti-human CCR4 (Research Diagnostics, Flanders, NJ) overnight at 4°C with gentle rotation. Goat IgG (Sigma) was used as a control. These samples were incubated with 25 μl protein A/G agarose beads for 2 h at 4°C, washed with 0.1% Brij, and resuspended in 10 μl SDS sample buffer. They were run on SDS/PAGE, transferred into polyvinylidene difluoride membranes (Millipore, Bedford, MA), and blocked with 5% BSA for 1 h at room temperature. The membranes were then incubated with 0.5 μg/ml anti-CCR4 for 2 h, washed three times in TBS containing 0.05% Tweed 20, and incubated with 1:5000 dilution of the secondary Abs. Development was done by enhanced chemiluminescence reagents (Pierce, Rockford, IL). For the endocytosis experiments, IANK cells (4 × 107/ml) were incubated with 50 ng/ml of the particular chemokine (MDC, TARC, or SDF-1α; all from R&D Systems) for 25 min at 37°C before the preparation of membranes from these cells.

Flow cytometric analysis

For the detection of CCR4 or CCR8, IANK cells were permeabilized first, before introduction of Abs, which detect the carboxy terminal of these receptors. For this purpose, 1 × 106/ml cells were fixed with 4% paraformaldehyde for 1 h at 4°C. They were washed twice in PBS and then incubated (5 × 105) with 150 μl of 1% saponin in PBS for 15 min at room temperature. The samples were centrifuged and resuspended in PBS containing 0.1% saponin and 0.1% FCS. These cells were incubated at 4°C for 45 min with 1 μg goat anti-human CCR4 (Research Diagnostics), goat anti-human CCR8 (made by B.D.), or as a control goat IgG. The cells were washed three times in a buffer containing 0.1% saponin and then incubated with 1:100 dilution of F(ab′)2 FITC-conjugated rabbit anti-goat (Southern Biotechnology, Birmingham, AL) for 45 min at 4°C. They were washed three times and then examined in FACScan (Becton Dickinson, Mountain View, CA). In the internalization experiments, the cells (4 × 106/100 μl) were incubated with 5 ng/100 μl MDC for 0–60 min at 37°C. These cells were extensively washed and then examined for the presence of CCR4 as described above.

Phosphorylation of CCR4

IANK cells (4 × 107/ml) were incubated with 50 ng/ml MDC for certain amounts of time (ranging between 0 and 5 min). The reactions were stopped by adding 500 μl ice-cold 2% Brij and were incubated on ice for 30 min. Lysates were collected from these cells and were immunoprecipitated overnight with 500 ng/ml anti-CCR4 or as a control with goat IgG. Protein A/G agarose beads were then added, and the mixtures were incubated for an additional 4 h. They were run on 7.5% SDS-PAGE and were blocked with 5% BSA. The samples were immunoblotted overnight with a 1:50 dilution of mouse anti-phosphoserine/phosphothreonine (Biomedia, Foster City, CA) in 5% BSA. Goat anti-mouse IgG diluted 1:5000 in Tween 20 + TBS was used as a secondary Ab. The same membranes were stripped and reimmunoblotted with 500 ng/ml goat anti-CCR4 and rabbit anti-goat IgG as a secondary Ab.

For the association of G protein-coupled receptor kinases (GRKs) with CCR4 in IANK cell membranes, these cells were either left intact or were stimulated with MDC (as above). Membranes were prepared from these cells and were immunoprecipitated with anti-CCR4. These membranes were run on SDS-PAGE and then immunoblotted with a 1:100 dilution of rabbit anti-human GRK2 or rabbit anti-human GRK3 (Santa Cruz Biotechnology, Santa Cruz, CA). Goat anti-rabbit (Bio-Rad, Hercules, CA) diluted at 1:5000 was used as a secondary Ab.

Analysis of CCR4 and CCR8 expression by multiprobe RNase protection assay (RPA)

Total RNA was prepared by guanidium thiocyanate/cesium chloride gradients following standard protocols. The specific mRNA for CCR4 and CCR8 was detected by the human cytokine receptor set 5 (hCR5) multiprobe template set (RiboQuant; PharMingen, San Diego, CA), which contains templates for CCR1, CCR2, CCR3, CCR4, CCR5, and CCR8. In brief, antisense RNA probes were generated from DNA templates using T7 DNA-dependent RNA polymerase in the presence of [α-32P]UTP (specific activity, 10 μCi/μl; Amersham Pharmacia Biotech, Uppsala, Sweden). Labeled probes were hybridized with total RNA (10 μg) overnight at 56°C. Unhybridized RNA was digested with RNase according to PharMingen’s supplied procedures. RNase-protected probes were resolved on denaturing 5% polyacrylamide gels. The gels were dried and exposed to film (BIOMAX MS; Eastman Kodak, Rochester, NY) at −70°C for 3 h.

Statistical analysis

Significant values were determined by using the two-tailed Student t test.

Results

Detection of mRNA for CCR8 and CCR4 in IANK cells

The expression of CCR4 and CCR8 at the mRNA level was examined utilizing the RPA. hCR5, which has templates for CCR4 and CCR8 among other chemokine receptors including CCR1, CCR2, CCR3, and CCR5, was utilized. Results in Fig. 1⇓ show that IANK cells contain mRNA for CCR4, CCR8, and CCR2 (lane 3). The expression of CCR1 and CCR3 was variable in different donors and is not shown in this figure. Surprisingly, CCR5 was absent in IANK cells. Receptors other than CCR4 and CCR8 have not been fully examined in this report. Yeast tRNA was included as a negative control and is shown in lane 2 of Fig. 1⇓.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Detection of CCR4 and CCR8 mRNA in IANK cells utilizing RPA. hCR5, which detects mRNA for CCR4 and CCR8 among other chemokine receptors, has been utilized. Detection of mRNA was as described in the procedures supplied by PharMingen. Lane 1, mRNA of RNase- unprotected probes. Lane 2, Yeast tRNA as a control. Lane 3, mRNA of protected probes in IANK cells. Arrows indicate the presence of mRNA for CCR4 and CCR8. Other chemokine receptors marked in the figure have not been examined in detail.

Detection of surface expression of CCR4 and CCR8

Fig. 2⇓a shows that IANK cells express CCR4 and CCR8 as detected by intracellular staining by Abs that bind the carboxy terminal of these receptors. Because the amount of anti-CCR8 in our possession was very scarce, we examined the expression of only CCR4 by other assays such as immunoblotting. Results in Fig. 2⇓b show that CCR4 is detected by this method (lane 1). Pretreatment of 4 × 107/ml IANK cells with 50 ng/ml MDC or TARC for 25 min at 37°C significantly reduced the expression of this receptor (Fig. 2⇓b, lanes 2 and 3, respectively), suggesting that CCR4 is internalized after pretreatment with these ligands. SDF-1α, which does not bind CCR4, did not induce the endocytosis of CCR4 (Fig. 2⇓b, lane 4). To examine in detail the kinetics of CCR4 endocytosis, we pretreated IANK cells with MDC for various periods of time and examined the presence of this receptor. Fig. 2⇓c shows that 5 min after stimulation, this receptor expression was low, with maximal internalization occurring between 15 and 45 min. Interestingly, this receptor started to reappear in the cell membranes 60 min after stimulation. This result suggests that the mechanism of disappearance of this receptor is due to its internalization and not to other mechanisms such as impediment of its recognition by the Ab due to ligand binding.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Expression of CCR4 and CCR8 in IANK cells. a, Expression of CCR4 and CCR8 was determined by flow cytometric analysis. Goat anti-human CCR4 or goat anti-human CCR8 was introduced inside permeabilized IANK cells, respectively. The cells were washed and then incubated with F(ab′)2 FITC-conjugated rabbit anti-goat as a secondary Ab. Filled columns represent the background controls in the presence of goat IgG plus the secondary Ab. b, Expression of CCR4 by immunoblot assay. IANK cell membranes were immunoprecipitated with anti-CCR4 and then immunoblotted with anti-CCR4 (lane 1). In lanes 2-4, the cells (4 × 107/ml) were incubated first with 50 ng/ml of TARC, MDC, or SDF-1α, respectively, for 25 min at 37°C before the membranes were prepared from these cells. These membranes were immunoprecipitated and then immunoblotted with anti-CCR4 as above. Lane 5 shows membranes immunoprecipitated with goat IgG as a control. c, Time kinetic study of CCR4 internalization. IANK cells (4 × 107/ml) were stimulated with 50 ng/ml MDC for 0, 5, 15, 30, 45, and 60 min. These cells were examined for the presence of CCR4 as determined in a.

Phosphorylation of CCR4

Phosphorylation of chemokine receptors is the first step in the process of endocytosis (reviewed in Ref. 3). Hence, we examined whether CCR4 is phosphorylated as a result of stimulation with MDC. Fig. 3⇓ shows that pretreatment of IANK cells with MDC for 0.5 min resulted in the phosphorylation of CCR4 (upper panel, lane 2) compared with unstimulated cells (upper panel, lane 1), as detected by Ab to phosphorylated serine/threonine residues. This phosphorylation was maximal by 1 min (upper panel, lane 3). It was also observed after 2 min but disappeared after 5 min of stimulation with MDC (upper panel, lanes 4 and 5, respectively). Immunoprecipitating NK cell membranes with goat IgG did not result in detecting the phosphorylated CCR4. Stripping the membranes and reimmunoblotting them with anti-CCR4 showed that the same amount of CCR4 is present in all samples (Fig. 3⇓, lower panel).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

MDC induces the phosphorylation of CCR4 in IANK cells. IANK cells (4 × 107/ml) were stimulated with 50 ng/ml MDC for 0–5 min. Lysates were prepared from these cells and were immunoprecipitated overnight with goat anti-CCR4 or with goat IgG as a control. They were run on SDS-PAGE and then immunoblotted with anti-phosphoserine/phosphothreonine (α-p). In the lower panel, the membranes were stripped and reimmunoblotted with anti-CCR4.

The serine/threonine kinases GRK2 and GRK3 have been implicated in phosphorylating chemokine receptors such as CCR5 (22). To address the possibility that CCR4 phosphorylation may be related to the activity of these enzymes, we examined whether CCR4 is associated with GRK2 or GRK3. Fig. 4⇓ shows that these enzymes are not present in IANK cell membranes. However, 0.5 min after stimulation with MDC, an association between CCR4 and GRK2 (Fig. 4⇓a) but not GRK3 (Fig. 4⇓b) occurred in these membranes. In contrast, after 1 min of stimulation, both GRK2 and GRK3 were associated with this receptor. Whereas GRK2 dissociated from the receptor 2 min after incubation with MDC, GRK3 was still associated with CCR4 at this time point. A similar amount of CCR4 was observed in these membranes upon stripping and reimmunoblotting with anti-CCR4 (Fig. 4⇓c).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Association of CCR4 with GRK2 and GRK3 shortly after stimulation of IANK cells with MDC. IANK cells were stimulated with MDC as described in Fig. 2⇑. Membranes were prepared from these cells and were immunoprecipitated with goat anti-CCR4 or with goat IgG as a control. These membranes were immunoblotted with rabbit anti-human GRK2 (a) or rabbit anti-human GRK3 (b). Goat anti-rabbit Ab was used as a secondary Ab. The membranes were stripped and reimmunoblotted with goat anti-CCR4 (c). Rabbit anti-goat Ab was used as a secondary Ab.

MDC, TARC, and I-309 induce the chemotaxis of IANK cells

To investigate the biological significance of the presence of CCR4 and CCR8, we examined the ability of IANK cells to respond to the ligands recognizing CCR4 and CCR8. Fig. 5⇓ shows that MDC, TARC, and I-309 induced a typical bell-shaped chemotactic response. As low as 1 pg/ml of TARC induced the chemotaxis of these cells (p < 0.0001 compared with cells migrating in the absence of chemokines), whereas 100 pg/ml is the minimum concentration of MDC and I-309 required to induce the chemotaxis of IANK cells (p < 0.01 and p < 0.001, respectively, compared with cells migrating in the presence of medium only). No significant migration was observed when chemokines were placed in the upper wells’ “negative gradients” or in the upper and lower wells’ “no gradients” (data not shown). Hence, the effect of these chemokines is a chemotactic rather than a chemokinetic response.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Effect of CC chemokines on the in vitro motility of IANK cells. Various concentrations (1–10,000 pg/ml) of MDC, TARC, or I-309 were placed in the lower wells of Boyden chambers, whereas 4 × 105 IANK cells were placed in the upper wells. Migration index was calculated as the number of cells migrating in the presence of chemokines divided by the number of cells migrating in the presence of medium only (open columns). Mean ± SD of six separate experiments. The effect of PT on MDC, TARC, and I-309 is shown in the lower right panel. In these experiments, IANK cells (1 × 106/ml) were either left intact (untreated) or were incubated with 2, 20, or 200 ng/ml activated PT overnight at 37°C. These cells were washed three times and placed in the upper wells of Boyden chambers. In the lower wells, 100 pg/ml of MDC, TARC, or I-309 was placed. Migration index was calculated as the number of cells migrating in the presence of chemokines divided by the number of cells migrating in the absence of chemokines (control; open columns). Mean ± SD of four separate experiments.

Almost all receptors for chemokines are coupled to heterotrimeric G proteins (1, 2, 3, 9). To investigate whether this is true for TARC, MDC, or I-309, we pretreated IANK cells with various concentrations of PT for 18 h at 37°C. Results in Fig. 5⇑ show that 2 ng/ml PT did not inhibit the chemotactic response induced by these chemokines. However, as low as 20 ng/ml inhibited TARC- or I-309-induced IANK cell chemotaxis (p < 0.004 and p < 0.005, respectively). A dose of 200 ng/ml PT inhibited MDC, TARC, and I-309-induced chemotaxis (p < 0.02, p < 0.001, and p < 0.001, respectively), suggesting that the chemotactic response induced by these three chemokines is mediated by PT-sensitive G proteins.

MDC, TARC, and I-309 induce the mobilization of [Ca2+]i in IANK cells

Because the pattern of calcium signaling in activated cells closely correlated to the pattern of receptor expression (23), we examined the ability of these chemokines to induce the mobilization of intracellular calcium. Fig. 6⇓ shows that MDC induced a potent calcium flux in IANK cells, an activity that was desensitized by the addition of MDC. Similarly, TARC induced a robust calcium flux in these cells, an activity that was desensitized by the addition of TARC. Surprisingly, MDC only partially inhibited the calcium flux response induced by TARC. The concentration of MDC utilized (20 ng/ml) was enough to desensitize CCR4, as shown in Fig. 6⇓. In contrast, TARC desensitized the calcium flux response induced by MDC. These results suggest that TARC in addition to CCR4 may utilize other receptors. Recent work has shown that in addition to CCR4, TARC utilizes CCR8 (24). Results in Fig. 6⇓ show that I-309, the ligand for CCR8, induced a robust calcium flux response in IANK cells. I-309 only partially inhibited the calcium flux induced by TARC, whereas TARC completely desensitized the calcium response induced by I-309. There was no cross-desensitization of the calcium flux response among MDC and I-309. These results suggest that in IANK cells, TARC shares the receptors utilized by MDC (CCR4) and I-309 (CCR8). However, MDC and I-309 do not share the same receptor. Because all three chemokines induced only a transient calcium flux in IANK cells, we included ionomycin (ION) as a control. This ionophore induced a sustained calcium flux in these cells in the presence of extracellular calcium, suggesting that it facilitates the influx of calcium across the plasma membranes.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

MDC, TARC, and I-309 induce the mobilization of [Ca2+]i in fura 2-AM-labeled IANK cells. The concentrations of chemokines used in this assay were 20 ng/ml MDC, 16 ng/ml TARC, and 20 ng/ml I-309. Ionomycin (ION) was used at 20 μM. Arrows indicate the times at which chemokines were added. Changes in the cytoplasmic level of Ca2+ were determined in a 90-s span.

To investigate whether the calcium flux response induced by these chemokines is PT-sensitive, we pretreated IANK cells with 200 ng/ml PT for 18 h before examining them in the calcium assay. Ionomycin was used as a control. In these assays, extracellular calcium was not added to the buffer. Ionomycin induced a transient calcium flux, which returned to a baseline level (Fig. 7⇓A), a normal response to this ionophore when incubated with cells in nominally Ca2+-free medium (25). Our results indicate that this ionophore can also induce the release of calcium from intracellular stores in NK cells. More importantly, PT did not inhibit the calcium response induced by this ionophore (Fig. 7⇓B). The calcium mobilization effect of MDC and TARC was completely inhibited upon pretreatment of IANK cells with PT (Fig. 7⇓, C–F). Surprisingly, the calcium flux induced by I-309 was not affected by prior treatment of these cells with PT (Fig. 7⇓, G and H).

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Effect of PT on the mobilization of intracellular calcium induced by MDC, TARC, and I-309. IANK cells (1 × 106/ml) were either left untreated (UNT) or were pretreated with 200 ng/ml of activated PT for 18 h at 37°C. The cells were extensively washed, labeled with fura 2-AM, and then examined in the calcium release assay. Ionomycin (ION) was used at 20 μM. The concentrations of chemokines are the same as in Fig. 6⇑. Arrows indicate the times at which these reagents were added. One of three representative experiments.

Discussion

Among other functions, chemokines inhibit the replication of HIV-1 (13, 14, 15, 16, 17). One possible scenario for this inhibition is the ability of NK cells to secrete and to respond to these chemokines. Activated NK cells collected from HIV-1-infected individuals have been shown to secrete MIP-1α, MIP-1β, and RANTES and to inhibit the in vitro replication of the M-tropic HIV-1 (26). In addition, NK cells that are recruited and activated by the CXC chemokines Mig and Crg-2 contributed significantly to the eradication of murine vaccinia virus (27). Also, NK cells respond by migrating toward the concentration gradients of the anti-HIV-1 chemokines (reviewed in Ref. 9). In this paper, we have added to the list of chemokines the CC chemokines TARC, MDC, and I-309. These chemotactic activities were inhibited upon pretreatment of IANK cells with PT. This toxin ADP-ribosylates the α subunit of members of Gi and Go proteins and hence uncouples them from the membranes. Our results suggest that TARC, MDC, and I-309 receptors are coupled to members of the Gi or Go proteins (3, 9). Also, we showed that these chemokines induce the accumulation of intracellular calcium in IANK cells.

Extravasation of NK cells into various tissues and their accumulation at the sites of HIV-1 replication must be accompanied by the expression of chemokine receptors in these cells. Also, expression of chemokine receptors corresponds to the chemotaxis and the calcium signaling induced by chemokines in T cells (23). In this paper we have clearly shown by several criteria including flow cytometric, biochemical, and molecular analyses that NK cells express CCR4. Messenger RNA for CCR4 or CCR8 was also detected in IANK cells. The expression of CCR4 and CCR8 explains how TARC, MDC, and I-309 induced the chemotaxis and the mobilization of intracellular calcium in these cells. When TER-1 (CCR8) was first cloned, its mRNA was detected in certain NK cell lines, such as NK 3.3, but not in others, such as NKL and YT-5, or in activated cells (6). In our study, it is clear that CCR8 is expressed in NK cells cultured with IL-2 both at the mRNA and on the surface and in terms of the response of these cells to the CCR8 ligands TARC and I-309. The difference between our study and that reported by Napolitano et al. (6) is that we used adherent IANK cells. These cells may express different chemokine receptors than nonadherent cells and may resemble the NK 3.3 chemokine receptor expression. In fact, both adherent IANK cells and the NK 3.3 cells respond similarly to various CC chemokines (19). Although not examined in any detail, we noticed that IANK cells lack mRNA for CCR5, the receptor for MIP-1β, MIP-1α, and RANTES.

Pretreatment of IANK cells with MDC or with TARC induced the internalization of CCR4. This occurred after 5 min of stimulation and was persistent until 45 min. Several steps must take place before G protein-coupled receptors such as CCR4 are internalized. These include the recruitment of GRKs, which phosphorylate the receptors and consequently bind β-arrestin (reviewed in Ref. 28). Chemokine receptors form appropriate targets for GRKs because these are serine/threonine kinases, and the carboxy terminal of the chemokine receptors are rich with these residues (reviewed in Refs. 1, 3). In this paper, we have shown that CCR4 is phosphorylated 0.5 min after incubation of NK cells with MDC. GRKs are most probably responsible for phosphorylating CCR4 because we observed that there is a sequential association of GRK2 and GRK3 with CCR4 shortly after stimulation with MDC.

Hence, GRK2 is recruited first, because it is associated with CCR4 0.5 min after incubation with MDC and seems to be responsible for the initial phosphorylation of CCR4 in IANK cells. Thereafter, GRK3 is recruited and remains associated with the phosphorylated receptors for the duration of the phosphorylation process, i.e., up to 2 min. It appears that GRK3 may maintain the receptor in its phosphorylated forms. Both GRK2 and GRK3 are dissociated from the receptor 5 min after stimulation. This is coincided with the loss of phosphorylation. Also, we observed that there is a lapse of time between the phosphorylation of the receptor (within seconds) and its endocytosis (between 5 and 45 min). This is most probably due to the fact that phosphorylated receptors are not internalized right after stimulation. We have evidence showing that after activation with MDC or TARC, phosphorylated CCR4 recruits β-arrestin and nonreceptor tyrosine kinases. Such recruitment starts 5 min after stimulation (data not shown). These molecules are important for directing phosphorylated receptors toward endocytic pits to start the process of internalization. Interestingly, CCR4 reappeared in NK cell membranes 60 min after stimulation, suggesting that this receptor is not degraded by endogenous proteolytic enzymes but instead is recycled into the membranes. This is important when one considers CCR4 as a target for therapy. Our results support those of others who observed that GRK3 phosphorylates CCR2B (29). In addition, GRK2 and GRK3 were reported to phosphorylate CCR5 and to induce its desensitization and endocytosis upon activation of various cell types with RANTES (22, 30).

It was suggested that in Th2 cells (31) or in L1.2 transfected cells (18), receptors other than CCR4 must bind MDC. Such receptors, if found, are most probably not expressed on NK cells, because in these cells TARC inhibited the calcium mobilization induced by MDC, suggesting that CCR4 is the only receptor utilized by MDC. Alternatively, a novel receptor that binds both MDC and TARC may be identified, which could explain the present results. However, our results suggest that in addition to CCR4, TARC utilizes some other receptors because MDC, the ligand for CCR4, partially inhibited the calcium mobilization response induced by TARC. This receptor is probably CCR8 because I-309, the ligand for CCR8, also partially inhibited the calcium mobilization response induced by TARC. This result supports the findings of Bernardini et al. (24), who showed that TARC utilizes CCR8 in the Jurkat cell line.

In the calcium release assays, we observed that the response induced by MDC, TARC, or I-309 is sharply declined 10–15 s after stimulation with these chemokines, suggesting a transient release of calcium from intracellular sources such as the endoplasmic reticulum. The calcium channels on these sources are thereafter closed until further stimulation. This stimulation is facilitated by G proteins, which recruit and activate phospholipase Cβ and hence the inositol 1,4,5 trisphosphate/inositol 1,4,5 trisphosphate receptor pathway or the ADP-ribosyl cyclase and hence the cyclic ADP-ribose/ryanodine receptor pathway (32). Both of these pathways are activated by chemokines in IANK cells (33). The calcium flux response induced by MDC and TARC is dependent on PT-sensitive G proteins because PT inhibited this response. Because the heterotrimeric G proteins are dissociated from IANK cell membranes shortly after stimulation with chemokines (21), it is not surprising that there is an initial calcium flux response induced by the three chemokines, which is desensitized until further association of the various subunits of G proteins with the receptors. Hence, this response will only be restored upon the reappearance of the receptor and its reassociation with the α, β, and γ subunits of G proteins, waiting for another round of stimulation. On the other hand, the calcium flux response induced by I-309 is not inhibited by PT, suggesting that this response is mediated through PT-insensitive G proteins. The nature of these G proteins is not known at the present time. This result marked a distinction between the chemotactic response, which is PT-sensitive, and the calcium response induced by I-309, supporting the findings of others who reported such a distinction between the two activities (chemotaxis and calcium flux) induced by chemokines in T cells (23).

In conclusion, our results are the first to show that NK cells express CCR4 and CCR8, among other chemokine receptors. This, combined with the ability of NK cells to secrete various chemokines, may explain how these cells extravasate into various tissues and may shed some light on the possible involvement of NK cells in eradicating HIV-1-infected cells. Also, our results indicate that CCR4 and CCR8 are not exclusive for Th2 cells.

Footnotes

  • ↵1 This work was supported by grants from the Norwegian Research Council, the Norwegian Cancer Society, Anders Jahres Fond, and Hydro, Norway. A.A.M. is a Senior Scientist of the Norwegian Cancer Society.

  • ↵2 Address correspondence and reprint requests to Dr. A. A. Maghazachi, Department of Anatomy, University of Oslo, P.O. Box 1105, N-0317 Blindern, Oslo, Norway. E-mail address: azzam.maghazachi{at}basalmed.uio.no

  • ↵3 Abbreviations used in this paper: CCR, CC chemokine receptor; TARC, thymus and activation-regulated chemokine; MDC, macrophage-derived chemokine; MIP, macrophage inflammatory protein; SDF, stromal-derived factor; IANK, IL-2-activated NK; PT, pertussis toxin; fura-2-AM, fura-2-acetoxymethyl ester; GRK, G protein-coupled receptor kinases; RPA, RNase protection assay; hCR5, human cytokine receptor set 5.

  • Received June 24, 1999.
  • Accepted February 4, 2000.
  • Copyright © 2000 by The American Association of Immunologists

References

  1. ↵
    Murphy, P. M.. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 12: 47
    OpenUrl
  2. ↵
    Luster, A.. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436
    OpenUrlCrossRefPubMed
  3. ↵
    Maghazachi, A. A.. 1999. Intracellular signalling pathways induced by chemokines in natural killer cells. Cell. Signalling 11: 385
    OpenUrlCrossRefPubMed
  4. ↵
    Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, O. Yoshie. 1997. The T cell-derived CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272: 15036
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Imai, T., D. Chantry, C. J. Raport, C. L. Wood, M. Nishimura, R. Godiska, O. Yoshie, P. W. Gray. 1998. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273: 1764
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Napolitano, M., A. Zingoni, G. Bernardini, G. Spinetti, A. Nista, C. T. Storlazzi, M. Rocchi, A. Santoni. 1996. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J. Immunol. 157: 2759
    OpenUrlAbstract
  7. ↵
    Tiffany, H. L., L. L. Lautens, J.-L. Gao, J. Pease, M. Locati, C. Combadiere, W. Modi, T. I. Bonner, P. M. Murphy. 1997. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J. Exp. Med. 186: 165
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Roos, R. S., M. Loetscher, D. F. Legler, I. Clark-Lewis, M. Baggiolini, B. Moser. 1997. Identification of CCR8, the receptor for the human CC chemokine I-309. J. Biol. Chem. 272: 17251
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Maghazachi, A. A., A. Al-Aoukaty. 1998. Chemokines activate natural killer cells through the heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 12: 913
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, P. W. Gray. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185: 1595
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D’Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Zingoni, A., H. Soto, J. A. Hedrick, A. Stoppocciaro, C. T. Storlazzi, F. Sinigaglia, D. D’Ambrosio, A. O’Garra, D. Robinson, M. Rocchi, et al 1998. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161: 547
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, P. Lusso. 1995. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, et al 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833
    OpenUrlCrossRefPubMed
  15. ↵
    Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829
    OpenUrlCrossRefPubMed
  16. ↵
    Horuk, R., J. Hesselgesser, Y. Zhou, D. Faulds, M. Halk-Miller, S. Harvey, D. Taub, M. Samson, M. Parmentier, J. Rucker, et al 1998. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem. 273: 386
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, A. L. DeVico. 1997. Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278: 695
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Struyf, S., P. Proost, S. Sozzani, A. Mantovani, A. Wuyts, E. De Clercq, D. Schols, J. Van Damme. 1998. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 161: 2672
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Maghazachi, A. A., A. Al-Aoukaty, T. J. Schall. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells: role for G proteins. J. Immunol. 153: 4969
    OpenUrlAbstract
  20. ↵
    Maghazachi, A. A., B. S. Skålhegg, B. Rolstad, A. Al-Aoukaty. 1997. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 11: 765
    OpenUrlAbstract
  21. ↵
    Al-Aoukaty, A., B. Rolstad, A. A. Maghazachi. 1999. Recruitment of pleckstrin and phosphoinositide 3-kinase γ into the cell membranes, and their association with Gβγ after activation of NK cells with chemokines. J. Immunol. 162: 3249
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Oppermann, M., M. Mack, A. E. I. Proudfoot, H. Olbrich. 1999. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J. Biol. Chem. 274: 8875
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Rabin, R. L., M. K. Park, F. Liao, R. Swofford, D. Stephany, J. M. Farber. 1999. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 162: 3840
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Bernardini, G., J. Hedrick, S. Sozzani, W. Luini, S. Spinetti, M. Weiss, S. Menon, A. Zlotnik, A. Mantovani, A. Santoni, M. Napolitano. 1998. Identification of the CC chemokine TARC and macrophage inflammatory protein-1β as novel functional ligands for the CCR8 receptor. Eur. J. Immunol. 28: 582
    OpenUrlCrossRefPubMed
  25. ↵
    Morgan, A. J., R. Jacob. 1994. Ionomycin enhances Ca2+ by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem. J. 300: 665
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Oliva, A., A. L. Kinter, M. Vaccarezza, A. Rubert, A. Catanzaro, S. Moir, J. Monaco, L. Ehler, S. Mizell, R. Jackson, et al 1998. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vivo. J. Clin. Invest. 102: 223
    OpenUrlCrossRefPubMed
  27. ↵
    Mahalingam, S., J. M. Farber, G. Karupiah. 1999. The interferon-inducible chemokine MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73: 1479
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Lefkowitz, R. J.. 1998. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273: 18677
    OpenUrlFREE Full Text
  29. ↵
    Franci, C., J. Gosling, C.-L. Tsou, S. R. Coughlin, I. F. Charo. 1996. Phosphorylation by a G protein-coupled kinase inhibits signaling and promotes internalization of the monocyte chemoattractant protein-1 receptor. J. Immunol. 157: 5606
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Zhao, J., L. Ma, Y.-L. Wu, P. Wang, W. Hu, G. Pei. 1998. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J. Cell. Biochem. 71: 36
    OpenUrlCrossRefPubMed
  31. ↵
    Andrew, D. P., M.-S. Chang, J. McNinch, S. T. Wathen, M. Rihanek, J. Tseng, J. P. Spellberg, C. G. Elias, III. 1998. STCP-1 (MDC) chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161: 502
    OpenUrl
  32. ↵
    Berridge, M., P. Lipp, M. Bootman. 1999. Calcium signalling. Curr. Biol. 9: R157
    OpenUrlCrossRefPubMed
  33. ↵
    Inngjerdingen, M., A. Al-Aoukaty, B. Damaj, A. A. Maghazachi. 1999. Differential utilization of cyclic ADP-ribose pathway by chemokines to induce the mobilization of intracellular calcium in NK cells. Biochem. Biophys. Res. Commun. 262: 467
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Immunology: 164 (8)
The Journal of Immunology
Vol. 164, Issue 8
15 Apr 2000
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human NK Cells Express CC Chemokine Receptors 4 and 8 and Respond to Thymus and Activation-Regulated Chemokine, Macrophage-Derived Chemokine, and I-309
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Human NK Cells Express CC Chemokine Receptors 4 and 8 and Respond to Thymus and Activation-Regulated Chemokine, Macrophage-Derived Chemokine, and I-309
Marit Inngjerdingen, Bassam Damaj, Azzam A. Maghazachi
The Journal of Immunology April 15, 2000, 164 (8) 4048-4054; DOI: 10.4049/jimmunol.164.8.4048

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Human NK Cells Express CC Chemokine Receptors 4 and 8 and Respond to Thymus and Activation-Regulated Chemokine, Macrophage-Derived Chemokine, and I-309
Marit Inngjerdingen, Bassam Damaj, Azzam A. Maghazachi
The Journal of Immunology April 15, 2000, 164 (8) 4048-4054; DOI: 10.4049/jimmunol.164.8.4048
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606